Medication Adherence and Behavior Change

Medication adherence and behavior change is the area of pharmacy practice concerned with how, and how consistently, patients take medicines as agreed with their prescriber, and with the behavioral science used to understand and support that process. It spans the definition and measurement of adherence, the barriers and beliefs that shape medicine-taking, behavioral models and pharmacist-led interventions, and the long-term continuation (persistence) of therapy.

Definition

Medication adherence is the extent to which a person's medicine-taking behavior corresponds with an agreed regimen from a healthcare provider; it is conventionally decomposed into initiation, implementation, and discontinuation (persistence), and is studied alongside the behavioral mechanisms that influence each phase.

Scope

The area treats adherence as a behavioral and pharmaceutical-care construct rather than as a moral judgement about patients. It covers terminology and taxonomy, measurement approaches, determinants of adherence, behavior change frameworks, and persistence over time. It frames pharmacist roles descriptively and does not provide individualized dosing or treatment instructions.

Sub-topics

• Adherence Barriers, Facilitators, and Root-Cause Analysis
• Behavior Change Models and Pharmacist-Led Interventions
• Medication Adherence: Definition, Measurement, and Assessment Methods
• Persistence, Continuation, and Long-Term Medication Use

Core questions

• How should adherence be defined and measured so that estimates are comparable across studies?
• What patient, regimen, condition, and system factors drive non-adherence?
• Which behavioral models and interventions improve medicine-taking, and how durable are the effects?
• How does persistence (continuation over time) differ from day-to-day implementation, and why does it matter for outcomes?

Key concepts

• Initiation, implementation, and discontinuation
• Adherence versus persistence
• Primary versus secondary non-adherence
• Intentional versus unintentional non-adherence
• Direct and indirect measurement methods
• Behavior change interventions
• Pharmaceutical care and shared decision-making

Key theories

ABC adherence taxonomy

A consensus framework that separates the process of medication adherence into initiation, implementation, and discontinuation, distinguishing adherence (a behavior) from persistence (its duration) and from the science of managing it.

Mechanisms

Non-adherence arises from interacting determinants that the World Health Organization grouped into five dimensions: socioeconomic, health-system, condition-related, therapy-related, and patient-related factors. Behavior is shaped both by capability and opportunity (regimen complexity, cost, access) and by motivation and beliefs (perceived necessity of treatment versus concerns about harm). The ABC taxonomy locates these influences across the initiation, implementation, and discontinuation phases, which helps target measurement and intervention to the point in the medicine-taking process where the behavior breaks down.

Clinical relevance

Non-adherence is common and is associated with poorer outcomes and increased health-system costs across many chronic conditions, which is why adherence support is a recurring focus of pharmaceutical care. This area describes how adherence is conceptualized, measured, and supported as a body of knowledge; it is educational reference material and not a source of individual treatment or dosing advice.

Epidemiology

Adherence to long-term therapy in chronic disease averages roughly half in developed countries, with substantial variation by condition and population, as synthesized in the World Health Organization's review of adherence to long-term therapies. Estimates depend heavily on the measurement method used, which is one reason standardized definitions are emphasized.

Evidence & guidelines

Cochrane and other systematic reviews find that interventions to improve adherence are often complex and yield modest, inconsistent effects, with limited evidence that improved adherence translates reliably into better clinical outcomes; the World Health Organization report remains a widely cited orienting framework. The evidence base motivates careful measurement and rigorous trial design rather than reliance on any single intervention.

History

Interest in medicine-taking moved from a paternalistic notion of 'compliance' toward 'adherence' and then 'concordance', reflecting a shift to patient partnership. The World Health Organization's 2003 report consolidated the multidimensional view of determinants, and the 2012 ABC taxonomy standardized terminology by separating the phases of adherence, providing a shared vocabulary for the field.

Debates

Compliance versus adherence versus concordance

The shift in terminology reflects a move away from framing patients as obedient or disobedient toward a collaborative, agreed regimen; the words carry different assumptions about the patient-provider relationship and remain contested.

Key figures

• Bernard Vrijens
• Sabina De Geest
• John Urquhart
• Lars Osterberg
• R. Brian Haynes

Seminal works

• vrijens-2012
• sabate-2003
• osterberg-2005
• nieuwlaat-2014

Frequently asked questions

What is the difference between adherence and persistence?

Adherence describes how closely day-to-day medicine-taking matches the agreed regimen (implementation), while persistence describes how long a person continues therapy before discontinuing. A person can be persistent yet have poor implementation, or implement well but stop early.

Why did the field move from 'compliance' to 'adherence'?

'Compliance' implies passively following orders, whereas 'adherence' reflects an agreement reached with the patient, acknowledging their role and beliefs in the decision to take a medicine.